154 related articles for article (PubMed ID: 9891555)
21. Comparison of the Radiation Therapy Oncology Group recursive partitioning classification and Union Internationale Contre le Cancer TNM classification for patients with head and neck carcinoma.
León X; Gich I; Orús C; Del Prado Venegas M; Ramón Gras J; Quer M
Head Neck; 2005 Mar; 27(3):248-57. PubMed ID: 15672358
[TBL] [Abstract][Full Text] [Related]
22. Prognostic factors in head and neck soft tissue sarcomas.
Dudhat SB; Mistry RC; Varughese T; Fakih AR; Chinoy RF
Cancer; 2000 Aug; 89(4):868-72. PubMed ID: 10951351
[TBL] [Abstract][Full Text] [Related]
23. Syndecan-1 expression has prognostic significance in head and neck carcinoma.
Anttonen A; Kajanti M; Heikkilä P; Jalkanen M; Joensuu H
Br J Cancer; 1999 Feb; 79(3-4):558-64. PubMed ID: 10027330
[TBL] [Abstract][Full Text] [Related]
24. A prospective population-based study of cutaneous malignant melanoma of the head and neck.
Gillgren P; Månsson-Brahme E; Frisell J; Johansson H; Larsson O; Ringborg U
Laryngoscope; 2000 Sep; 110(9):1498-504. PubMed ID: 10983950
[TBL] [Abstract][Full Text] [Related]
25. Identification of clinically useful cancer prognostic factors: what are we missing?
McShane LM; Altman DG; Sauerbrei W
J Natl Cancer Inst; 2005 Jul; 97(14):1023-5. PubMed ID: 16030294
[No Abstract] [Full Text] [Related]
26. Prognostic significance of head-and-neck cancer biomarkers previously discovered and identified using iTRAQ-labeling and multidimensional liquid chromatography-tandem mass spectrometry.
Matta A; DeSouza LV; Shukla NK; Gupta SD; Ralhan R; Siu KW
J Proteome Res; 2008 May; 7(5):2078-87. PubMed ID: 18407684
[TBL] [Abstract][Full Text] [Related]
27. Prognostic factors in head and neck rhabdomyosarcoma.
Simon JH; Paulino AC; Smith RB; Buatti JM
Head Neck; 2002 May; 24(5):468-73. PubMed ID: 12001077
[TBL] [Abstract][Full Text] [Related]
28. Molecular markers for diagnosis and prognosis.
Partridge M; Gaballah K; Huang X
Cancer Metastasis Rev; 2005 Jan; 24(1):71-85. PubMed ID: 15785873
[TBL] [Abstract][Full Text] [Related]
29. Comorbidity is a prognostic factor in elderly patients with head and neck cancer.
Sanabria A; Carvalho AL; Vartanian JG; Magrin J; Ikeda MK; Kowalski LP
Ann Surg Oncol; 2007 Apr; 14(4):1449-57. PubMed ID: 17235712
[TBL] [Abstract][Full Text] [Related]
30. National Cancer Data Base report on osteosarcoma of the head and neck.
Smith RB; Apostolakis LW; Karnell LH; Koch BB; Robinson RA; Zhen W; Menck HR; Hoffman HT
Cancer; 2003 Oct; 98(8):1670-80. PubMed ID: 14534884
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of P53 histochemistry and DNA histogram parameters in head and neck malignancies.
Tamás L; Kraxner H; Mechtler L; Répássy G; Ribári O; Hirschberg A; Szentkúti G; Járay B; Szentirmay Z
Anticancer Res; 2000; 20(5C):4031-7. PubMed ID: 11268497
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of skin testing with dinitrochlorobenzene in patients with head and neck cancer.
Osoba D; Kersey PA; Clark RM; Rosen IB
Can J Surg; 1980 Jan; 23(1):43-4. PubMed ID: 7363157
[TBL] [Abstract][Full Text] [Related]
33. A critical appraisal of prognostic and predictive factors for common lung cancers.
Thunnissen FB; Schuurbiers OC; den Bakker MA
Histopathology; 2006 Jun; 48(7):779-86. PubMed ID: 16722925
[TBL] [Abstract][Full Text] [Related]
34. [Prognostic factors for head and neck cancer].
Fujieda S
Gan To Kagaku Ryoho; 2001 Apr; 28(4):440-7. PubMed ID: 11329776
[TBL] [Abstract][Full Text] [Related]
35. Epidermal growth factor receptor: a novel biomarker for aggressive head and neck cutaneous squamous cell carcinoma.
Ch'ng S; Low I; Ng D; Brasch H; Sullivan M; Davis P; Tan ST
Hum Pathol; 2008 Mar; 39(3):344-9. PubMed ID: 18045646
[TBL] [Abstract][Full Text] [Related]
36. [Standards, Options and Recommendations (SOR) for tumor markers in breast cancer. SOR Working Group].
Basuyau JP; Blanc-Vincent MP; Bidart JM; Daver A; Deneux L; Eche N; Gory-Delabaere G; Pichon MF; Riedinger JM
Bull Cancer; 2000 Oct; 87(10):723-37. PubMed ID: 11084536
[TBL] [Abstract][Full Text] [Related]
37. Importance of molecular analysis in detecting cervical lymph node metastasis in head and neck squamous cell carcinoma.
Elsheikh MN; Rinaldo A; Hamakawa H; Mahfouz ME; Rodrigo JP; Brennan J; Devaney KO; Grandis JR; Ferlito A
Head Neck; 2006 Sep; 28(9):842-9. PubMed ID: 16691557
[TBL] [Abstract][Full Text] [Related]
38. Pretreatment quality of life predicts for locoregional control in head and neck cancer patients: a radiation therapy oncology group analysis.
Siddiqui F; Pajak TF; Watkins-Bruner D; Konski AA; Coyne JC; Gwede CK; Garden AS; Spencer SA; Jones C; Movsas B
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):353-60. PubMed ID: 17889449
[TBL] [Abstract][Full Text] [Related]
39. Is immunohistochemical epidermal growth factor receptor expression overestimated as a prognostic factor in head-neck squamous cell carcinoma? A retrospective analysis based on a tissue microarray of 365 carcinomas.
Fischer C; Zlobec I; Stöckli E; Probst S; Storck C; Tornillo L; Lugli A; Wolfensberger M; Terracciano L
Hum Pathol; 2008 Oct; 39(10):1527-34. PubMed ID: 18620726
[TBL] [Abstract][Full Text] [Related]
40. Is head and neck melanoma a distinct entity? A clinical registry-based comparative study in 5702 patients with melanoma.
Hoersch B; Leiter U; Garbe C
Br J Dermatol; 2006 Oct; 155(4):771-7. PubMed ID: 16965427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
